✦ LIBER ✦

Duloxetine in treatment of anxiety symptoms associated with depression

✍ Scribed by David L. Dunner; David J. Goldstein; Craig Mallinckrodt; Yili Lu; Michael J. Detke

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 119 KB
Volume: 18
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.10122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Escitalopram in the treatment of anxiety

Escitalopram in the treatment of anxiety symptoms associated with depression

✍ Borwin Bandelow; Henning F. Andersen; Ornah T. Dolberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Time course of depression-symptom improv

Time course of depression-symptom improvement during treatment with duloxetine

✍ Robert M.A. Hirschfeld; Craig Mallinckrodt; Thomas C. Lee; Michael J. Detke 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

The aim of this study was to examine the longitudinal response for overall and individual symptoms during the treatment of major depressive disorder. Data were pooled from two 9-week trials, which compared duloxetine 60-mg QD (n ¼ 251) with placebo (n ¼ 261) in the treatment of MDD. Changes from bas

Efficacy of duloxetine in the treatment

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms

✍ James M. Russell; Risa Weisberg; Maurizio Fava; James T. Hartford; Janelle S. Er 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

The efficacy of nefazodone augmentation

The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder

✍ Fletcher B. Taylor; Maureen R. Prather 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Depression that fails to respond to multiple antidepressant trials, particularly when accompanied by anxiety, constitutes a difficult treatment challenge. Those with anxious depression may be less likely to respond to treatment than their cohorts without anxiety. Anxiety symptoms also predict a high

Pilot study of duloxetine for treatment

Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms

✍ N. Lynn Henry; Mousumi Banerjee; Max Wicha; Catherine Van Poznak; Jeffrey B. Sme 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract ## BACKGROUND: Approximately 50% of postmenopausal women with hormone receptor‐positive early stage breast cancer treated with an aromatase inhibitor (AI) develop musculoskeletal symptoms. Standard analgesics are relatively ineffective. Duloxetine is a serotonin norepinephrine reuptake

Symptoms of anxiety in depression: asses

Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression

✍ Anthony L. Vaccarino; Kenneth R. Evans; Terrence L. Sills; Amir H. Kalali 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views